Background:

DNQX (FG 9041) is a AMPA receptor antagonists.

DNQX (FG 9041), added 2 h after cell plating, induces a dose-dependent neurotoxicity.

[1]. Watkins JC et al. Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. Trends Pharmacol Sci. 1990 Jan;11(1):25-33. [2]. Honoré T et al. Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists. Science. 1988 Aug 5;241(4866):701-3.